S

Supernus Pharmaceuticals

Specialty CNS pharmaceuticals developer and marketer

Overview

Supernus Pharmaceuticals develops and commercializes medications for CNS diseases. It is fully integrated, handling R&D, manufacturing, and commercialization, and earns revenue from product sales and licensing; US sales target neurologists and psychiatrists with a specialty sales force, while international markets rely on partnerships. The company uses proprietary drug-delivery technologies—Microtrol, Solutrol, and EnSoTrol—to create extended-release formulations. Its portfolio includes Qelbree, Gocovri, Oxtellar XR, Trokendi XR, and ZURZUVAE from Sage Therapeutics, with growth driven by acquisitions and collaborations.

Work here?Claim your company

About Supernus Pharmaceuticals

Simplify's Rating
Not yet rated

We're working on gathering enough insights on this company, check back soon!

Industries

Industrial & ManufacturingBiotechnologyHealthcare

Company Size

501-1,000

Company Stage

IPO

Headquarters

Rockville, MD

Founded

2005

Get referred to Supernus Pharmaceuticals

See people who can refer or advise you

Funding

Total Funding

$679.5M

Above

Industry Average

Funded Over

6 Rounds

Post IPO Debt funding comparison data is currently unavailable. We're working to provide this information soon!
Post IPO Debt Funding Comparison Coming Soon

Benefits

  • Health Insurance
  • Dental Insurance
  • Vision Insurance
  • Paid Vacation
  • 401(k) Company Match
  • Life Insurance
  • Wellness Program
  • Stock Options
  • Employee Stock Purchase Plan
  • Company Equity

Stock Price

Growth & Insights

6 month growth

1%

1 year growth

3%

2 year growth

3%

Recently Posted Jobs

Sign up to get curated job recommendations

Supernus Pharmaceuticals is Hiring for 43 Jobs on Simplify!

Find jobs on Simplify and start your career today

Don't see your dream role? Check out thousands of other roles on Simplify.Browse all jobs